See All Slides - tctmd.com

Slides

Presentation TCT 2015

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Prasugrel for Primary PCI Is Simplest and Best!

Presenter: C. Michael Gibson, Marco Valgimigli, Sigmund Silber

October 11, 2015

Presentation TCT 2015

The Retrograde Approach: Euro CTO Insights

Presenter: J. Aaron Grantham, Masahiko Ochiai, Georgios Sianos

October 11, 2015

Presentation TCT 2015

France Presents: French Absorb Registry Indications and In-Hospital Results

Presenter: George D. Dangas, Eric Van Belle, René Koning

October 11, 2015

Presentation TCT 2015

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Oral or Crushed Ticagrelor for All!

Presenter: C. Michael Gibson, Marco Valgimigli, Guido Parodi

October 11, 2015

Presentation TCT 2015

What Have We Learned From All-Comers Head-to-Head DES Trials I? The SORT OUT Trial

Presenter: Stephen G. Ellis, John A. Ormiston, Evald H. Christiansen

October 11, 2015

Presentation TCT 2015

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Presenter: Gary M. Ansel, Michael R. Jaff

October 11, 2015

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Prospective Identification of NonFlow Limiting Vulnerable Plaques and Vulnerable Patients: Data From Grayscale and RF-IVUS, OCT, and NIRS for Predicting Future Events

Presenter: Fernando Alfonso, Akiko Maehara, David Erlinge

October 11, 2015

Presentation TCT 2015

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan Tijssen, John L. Petersen

October 11, 2015

Presentation TCT 2015

Transeptal Puncture for Mitral Valve Interventions: Indications and Techniques

Presenter: Mohamed Chettibi, Ziyad M. Hijazi

October 11, 2015

Advertisement

Slides

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Prasugrel for Primary PCI Is Simplest and Best!

The Retrograde Approach: Euro CTO Insights

France Presents: French Absorb Registry Indications and In-Hospital Results

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Oral or Crushed Ticagrelor for All!

What Have We Learned From All-Comers Head-to-Head DES Trials I? The SORT OUT Trial

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Prospective Identification of NonFlow Limiting Vulnerable Plaques and Vulnerable Patients: Data From Grayscale and RF-IVUS, OCT, and NIRS for Predicting Future Events

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Transeptal Puncture for Mitral Valve Interventions: Indications and Techniques

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content